nelfinavir has been researched along with HIV-Associated Lipodystrophy Syndrome in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haugaard, SB | 1 |
| Boyko, EJ; Bryson, CL; Ioannou, GN; Weiss, NS | 1 |
| Bashan, N; Hollander, L; Klein, J; Kovsan, J; Maissel, A; Mazor, L; Meier, B; Osnis, A; Ovadia, S; Rudich, A; Tarnovscki, T | 1 |
| Chow, WA; Fousek, K; Frankel, P; Guan, M; Hepner, E; Magnusson, R; Mott, M; Pan, J; Synold, T; Tinsley, R; Valdes, F; Xi, B | 1 |
| Dubé, MP; Grinspoon, SK; Meyer, WA; Mulligan, K; Parker, RA; Robbins, GK; Roubenoff, R; Shafer, RW; Snyder, SW; Tebas, P; Wininger, DA; Zackin, RA | 1 |
| Dubé, MP; Grinspoon, SK; Komarow, L; Mulligan, K; Parker, RA; Robbins, GK; Roubenoff, R; Tebas, P | 1 |
1 review(s) available for nelfinavir and HIV-Associated Lipodystrophy Syndrome
| Article | Year |
|---|---|
Alteration in pancreatic islet function in human immunodeficiency virus.
Topics: Carbamates; Furans; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Indinavir; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Nelfinavir; Ritonavir; Sulfonamides | 2014 |
3 trial(s) available for nelfinavir and HIV-Associated Lipodystrophy Syndrome
| Article | Year |
|---|---|
Phase I study of nelfinavir in liposarcoma.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Drug Administration Schedule; Female; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Liposarcoma; Male; Middle Aged; Nelfinavir; Research Design; Treatment Outcome | 2012 |
Glucose metabolism, lipid, and body fat changes in antiretroviral-naive subjects randomized to nelfinavir or efavirenz plus dual nucleosides.
Topics: Absorptiometry, Photon; Adipose Tissue; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Blood Glucose; Cyclopropanes; Drug Therapy, Combination; Dyslipidemias; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Insulin Resistance; Lipids; Male; Nelfinavir; Nucleosides; Oxazines | 2005 |
Long-term body fat outcomes in antiretroviral-naive participants randomized to nelfinavir or efavirenz or both plus dual nucleosides. Dual X-ray absorptiometry results from A5005s, a substudy of Adult Clinical Trials Group 384.
Topics: Absorptiometry, Photon; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Body Composition; Cyclopropanes; Didanosine; Drug Therapy, Combination; Female; HIV; HIV Infections; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Male; Middle Aged; Nelfinavir; Prospective Studies; Stavudine; Time Factors; Treatment Outcome; United States; Zidovudine | 2007 |
2 other study(ies) available for nelfinavir and HIV-Associated Lipodystrophy Syndrome
| Article | Year |
|---|---|
Associations between lipodystrophy or antiretroviral medications and cirrhosis in patients with HIV infection or HIV/HCV coinfection.
Topics: Adult; Aged; Antiretroviral Therapy, Highly Active; Case-Control Studies; Coinfection; Didanosine; Female; Hepatitis C; Hispanic or Latino; HIV Infections; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Liver Cirrhosis; Male; Middle Aged; Nelfinavir; Reverse Transcriptase Inhibitors; Risk Factors; Stavudine; Time Factors | 2015 |
Depot-specific adipocyte cell lines reveal differential drug-induced responses of white adipocytes--relevance for partial lipodystrophy.
Topics: Adipocytes, White; Adipogenesis; Adipose Tissue; Animals; Antiretroviral Therapy, Highly Active; Body Fat Distribution; Cell Differentiation; Cell Line; Gene Expression Regulation; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Mice; Nelfinavir; Organ Specificity; Rats; Rats, Sprague-Dawley | 2009 |